Trial Profile
A Multicenter Trial Evaluating the Efficacy of Cesamet for the Symptomatic Treatment of Pain in Patients With Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Feb 2008
Price :
$35
*
At a glance
- Drugs Nabilone (Primary)
- Indications Pain
- Focus Therapeutic Use
- 14 Feb 2008 Status change from in progress to completed, as reported by clinicaltrials.gov.
- 07 Feb 2007 New trial investigators added.
- 14 Oct 2006 New trial record.